This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
The Lung Cancer Policy Network aims to build momentum for policy action around lung cancer screening. As part of this, we will soon launch an interactive map collating research on the implementation of low-dose computed tomography (LDCT) screening from around the world.
The map is being developed in close consultation with our Network members, who are world-renowned experts in lung cancer and lung cancer screening.
A global snapshot of screening implementation
The aim of the interactive map is to facilitate the sharing of best practice and to guide policy development around using LDCT screening to detect lung cancer. It is designed to be a comprehensive resource that collates ongoing and completed implementation research for LCDT screening globally.
In addition to the map, an interactive data dashboard will enable the direct comparison of different approaches to screening adopted at the local, national or global level. The dashboard will showcase examples of current organised lung cancer screening and the status of early detection of lung cancer.
A tool that facilitates policy discussions
The map can be used by policymakers, researchers and lung cancer advocates to support policy discussions around the status of and evidence for detecting lung cancer earlier. It can also facilitate data sharing between different stakeholders – case studies from the map can inform and promote the implementation of LDCT screening in new locations.
The first edition of the interactive map will be launched on our website in September.
Recent news
News
Network produces recommendations for lung cancer screening in Asia Pacific
The Lung Cancer Policy Network recently hosted a collaborative workshop with the Asia Pacific Coalition Against Lung Cancer during the Asia Conference on Lung Cancer.
Blog
2024 reflections: a year of progress across the global lung cancer community
More people have access to LDCT screening than ever before. This year, four more countries have made a formal commitment to implement LDCT screening for lung cancer, and several implementation studies are under way.
Case study
Building evidence to inform future roll-out of lung cancer screening in Estonia
We examine the key evidence used to inform the development of a national screening programme for lung cancer in Estonia from 2021 to date.